Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | AGXT | P21549 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2364087 | 0.94 | TSHR (0.36) | TSHRTRPA1IDO1ALDH1A1AGXT | |
| SCHEMBL2345113 | 0.77 | TSHR (0.33) | TSHRTRPA1IDO1ALDH1A1AGXT | |
| SCHEMBL2349740 | 0.74 | — | — | |
| SCHEMBL2328694 | 0.73 | TSHR (0.35) | TSHRTRPA1IDO1ALDH1A1AGXT | |
| SCHEMBL2345548 | 0.71 | TSHR (0.36) | TSHRIDO1ALDH1A1AGXTCA1 | |
| SCHEMBL2345119 | 0.71 | TSHR (0.36) | TSHRIDO1AGXTCA1MAPT | |
| SCHEMBL2346576 | 0.70 | TSHR (0.35) | TSHRIDO1AGXT | |
| SCHEMBL2346569 | 0.69 | TSHR (0.34) | TSHRIDO1AGXT | |
| SCHEMBL29403866 | 0.67 | CHRM3 (0.40) | TSHRALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL2322367 | 0.67 | TSHR (0.39) | TSHRIDO1ALDH1A1AGXTCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1760085-B1 | PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES | ASAHI KASEI CHEMICALS CORP (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-7541482-B2 | Process for production of alkyltin alkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-06-02 | — | — | US | disclosed |
| US-20080275262-A1 | Process for Production of Alkyltin Alkoxides | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1760085-A1 | PROCESS FOR PRODUCTION OF ALKYLTIN ALKOXIDES | Asahi Kasei Chemicals Corporation (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275262-A1 | Process for Production of Alkyltin Alkoxides | ALK, MOGAT2, SOAT2 | TSHR 349/4885TRPA1 235/4885IDO1 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.